Wrotek, A., Jackowska, T. A noninferiority randomized open-label pilot study of 3- versus 7-day influenza postexposure prophylaxis with oseltamivir in hospitalized children. Sci Rep 14, 14192 (2024)
Short influenza postexposure prophylaxis (PEP) showed high efficacy in adults, but studies in children are lacking. This randomized open-label pilot trial aimed to verify noninferiority of a 3- versus 7-day prophylaxis with oral oseltamivir in hospitalized children. Influenza contacts were randomized to the 3- or 7-day group and efficacy, relative risk of adverse events (AEs), and the cumulative costs of drugs and AEs management were compared. The intention-to-treat (ITT) analysis included 59 children (n?=?28 and n?=?31 in the 3- and 7-day group, respectively). The efficacy was 100% (95% CI 87.7–100%) versus 93.6% (95% CI 78.6–99.2%) in the 3- and 7-day group; the differences were statistically insignificant. A per-protocol (PP) analysis including 56 patients (n?=?27 and n?=?29, respectively) showed 100% (95% CI 87.2–100%) and 93.1% (95% CI 77.2–99.2%) efficacy, respectively, without statistical significance. Differences were within the predefined noninferiority margin with an efficacy difference Δ?=?6.45 percentage points (p.p.) with 1-sided 95% CI (? 2.8, ? 1.31, p?=?0.86; ITT) and Δ?=?6.9 p.p. (1-sided 95% CI ? 2.83, ? 1.27, p?=?0.85; PP). Adverse events did not differ significantly, while the cumulative costs of the prophylaxis and AEs management were higher in the 7-day group (median 10.5 euro vs. 4.5 euro, p?0.01). This pilot study showed the noninferiority of the 3-day versus 7-day PEP, which was associated with lower costs.
See Also:
Latest articles in those days:
- Multiplexed Antibody Sequencing and Profiling of the Human Hemagglutinin-specific Memory B Cell Response following Influenza Vaccination 41 minute(s) ago
- A Rapid Virus-Free Method for Producing Influenza HA Immunogen Needed for Preparation of Influenza Vaccine Potency Antisera Reagents 42 minute(s) ago
- Interim Guidance for Employers to Reduce the Risk of Novel Influenza A for People Working with or Exposed to Animals 46 minute(s) ago
- Molecular characterisation of influenza B virus from the 2017/18 season in primary models of the human lung reveals improved adaptation to the lower respiratory tract 2 days ago
- Survivability of H5N1 Avian Influenza Virus in Homemade Yogurt, Cheese and Whey 2 days ago
[Go Top] [Close Window]